David Weinberg
Chief Executive Officer Parcelbio
David Weinberg is the co-founder and CEO of ParcelBio. He was previously VP of RNA Platform at Orbital Therapeutics / Circ Bio, where he led the development of a circular RNA therapeutics platform. Before that, he was Senior Director of Molecular Research at Freenome, where he built the multiomics diagnostics platform that enabled a blood test for the early detection of cancer. David obtained his PhD from MIT, was a UCSF Faculty Fellow, and has been honored with Forbes ‘30 Under 30’ and an NIH Early Independence Award.
Seminars
Tuesday 21st July 2026
Stabilizer Elements are a Modular Linear mRNA Platform for Potent & Durable Therapeutic Protein Expression
12:30 pm
- • Introducing Stabilizer Elements as a modular mRNA technology that provides potent and durable (i.e., circular RNAlike) therapeutic protein expression from linear mRNA
- Stabilizer Elements can be used to engineer mRNA in vivo CAR-T cell therapy with best-in-class ability to deplete peripheral and tissue-resident B cells
- The Stabilizer Element mRNA platform is a superior alternative to circular RNA due to its enhanced performance across diverse cellular contexts, simpler manufacturing, and compatibility with N1-methylpseudouridine
